Revascular Bio
Company

Revascular Bio

Pharmaceutical Manufacturing Suita-shi Osaka, Jp 2 employees
Employees
2

Revascular Bio Overview

Headquarters
Suita-shi Osaka, Jp
Industry
Pharmaceutical Manufacturing
Employees
2
Founded
2022
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About Revascular Bio

We have developed the world's first discovery of vascular-specific stem cells as cell therapy, providing groundbreaking solutions for the patients suffering from unresolved microvascular diseases. Our patented seed technology, vascular endothelial stem cells, is distributed in blood vessels throughout the body and is essential for the maintenance and regeneration of blood vessels in the body. We provide novel solutions for many microvascular diseases through two therapeutic concepts. The first is angiogenesis therapy, which can be applied to digital ulcers of systemic sclerosis, diabetic wounds, critical limb ischemia, vascular dementia, breast reconstruction, etc. The second, with angiocrine therapy, it is possible to completely cure hemophilia and lysosomal storage disorder through cell transplantation.

Revascular Bio Contact Details

People in AeroLeads
1

Revascular Bio Org Chart

Sample employees and titles
Name Title Contact
Kazuo Omori CEO of Revascular Bio/ Md
View

Compare Similar Companies to Revascular Bio